Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening

Pancreas

Volumn 45, Issue 7, 2016, Pages 1062-1066

  Hur, Chin ^a   Tramontano, Angela C ^a   Dowling, Emily C ^a   Brooks, Gabriel A ^a,b   Jeon, Alvin ^a   Brugge, William R ^a   Gazelle, G Scott ^a   Kong, Chung Yin ^a   Pandharipande, Pari V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

adenocarcinoma; pancreas; pancreatic cancer; pancreatic neoplasms; SEER registry; survival

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; CANCER SCREENING; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CARCINOMA IN SITU; COHORT ANALYSIS; EARLY CANCER; FEMALE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; VERY ELDERLY; AGE; CANCER REGISTRY; CARCINOMA, PANCREATIC DUCTAL; EARLY CANCER DIAGNOSIS; FORECASTING; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PANCREAS; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TRENDS; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; FORECASTING; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 84951309710     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000587     Document Type: Article

References (25)

1. American Cancer Society: Cancer Facts and Figures 2015. Atlanta, GA: American Cancer Society; 2015.
2. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913-2921.
3. Surveillance Epidemiology and End Results. SEER Stat Fact Sheet. Available at: http://seer.cancer.gov/statfacts/html/pancreas.html. Accessed March 4, 2015.
4. Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-919.
5. Tabár L, Vitak B, Chen HH, et al. The Swedish two-county trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin N Am. 2000;38:625-651.
6. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl JMed. 2011;365:395-409.
7. Schoen RE, Pinsky PF,Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl JMed. 2012;366: 2345-2357.
8. Atkin WS, Edwards R, Kralj-Hans I, et al. UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624-1633.
9. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-437.
10. Hakama M, Louhivuori K. A screening programme for cervical cancer that worked. Cancer Surv. 1988;7:403-416.
11. Hakama M, Miller AB, Day NE. Screening for Cancers of the Uterine Cervix. IARC Scientific Publication. No. 76. Lyon: IARC Press; 1986.
12. Sigurdsson K. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand. 1999;78:478-485.
13. Lynge E. Screening for cancer of the cervix uteri.World J Surg. 1989;13:71-78.
14. Pandharipande PV, Heberle C, Dowling EC, et al. Targeted screening of individuals at high risk for pancreatic cancer: results of a simulationmodel. Radiology. 2015;275:177-187.
15. Klein AP, Lindström S, Mendelsohn JB, et al. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One [serial online]. 2013;8:e72311. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal. pone.0072311. Accessed March 6, 2015.
16. Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol. 2006;4:766-781.
17. Canto MI, Harinck F, Hruban RH, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62: 339-347.
18. Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786-795.
19. Surveillance Epidemiology and End Results Program (www.seer.cancer.gov) Research Data (1973-2011), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014, based on the November 2013 submission.
20. Franko J, Hugec V, Lopes TL, et al. Survival among pancreaticoduodenectomy patients treated for pancreatic head cancer <1 or 2 cm. Ann Surg Oncol. 2013;20:357-361.
21. Goggins M. Markers of pancreatic cancer: working toward early detection. Clin Cancer Res. 2011;17:635-637.
22. Canto MI, Hruban RH, Fishman EK, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142:796-804.
23. Li H, Li Y, Cui L, et al. Monitoring pancreatic carcinogenesis by the molecular imaging of cathepsin E in vivo using confocal laser endomicroscopy. PLoS One [serial online]. 2014;9:e106566. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal. pone.0106566. Accessed March 9, 2015.
24. Rhim AD, Thege FI, Santana SM, et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology. 2014;146:647-651.
25. Ting DT, Wittner BS, Ligorio M, et al. Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep. 2014;8:1905-1918.